This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. The guideline aims to reduce variation in practice.
In January 2016, recommendation 1.3.6 was updated to clarify the risk factors for and stratification of risk of developing a diabetic foot problem.
The guideline includes recommendations on:
- care within 24 hours
- care across all care settings
- referral for diabetic foot problems
- investigating and managing diabetic foot ulcer, diabetic foot infection and Charcot arthropathy
Who is it for?
- Healthcare professionals that care for people with diabetes
- Commissioners and providers of diabetes foot care services
- People with diabetes, and their families and carers
Guideline development process
This guideline updates and replaces NICE guidelines CG10 (January 2004) and CG119 (March 2011), and the recommendations on foot care in NICE guideline CG15 (July 2004).
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.
All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.